drug: selegiline

• Clinical class: Anti-Parkinsonian; anti-depressant
• Action: Monoamine Oxidase Inhibitors (MAOI)
• Chemical class: levorotatory acetylenic derivative of phenethylamine
• CSA schedule: none
• DEA number: none
• Also: l-deprenyl
• MEDLINEplus^® Drug Information

U.S. Preparations:

• Eldepril^® (Somerset) FDA approved:
   5.15.1996 for treatment of Parkinson's Disease as an adjunct to levodopa/carbidopa
• Emsam^® (Somerset) FDA approved:
  2.27.2006 for treatment of depression
  U.S. Prescribing information
• Selegiline HCl Tablets, USP (Apotex)
• Selegiline HCl Tablets, USP (Endo Pharmaceuticals Inc.) FDA approved:
  for treatment of Parkinson's Disease as an adjunct to levodopa/carbidopa
  U.S. Prescribing information
• Zelapar^® orally disintegrating tablets (Valeant) FDA approved:
  6.14.2006 as an adjunct in the management of patients with  Parkinson's Disease being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy.
  U.S. Prescribing information

Preparations Outside U.S.:

• Ambo-neural, Amboneural, Amindan, Antiparkin, Cognitiv, Cosmopril, Deprenyl, Deprilan, Egibren, Julap, Jumex, Jumexal, Kinabide, Movergan, Moverin, Novo-Selegine, Parkinyl, Plurimen, Procythol, Regepar, Seledat, Selegam, Selegiline, Selepar, Selepark, Selepark, Seletop, Selgene, Selpar, Sepatrem, Tremorex, Vivapryl, Zelapon

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®